Lexaria Bioscience LEXX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 11.7 | 100.05 | -1.2 | -1,994 | -2 | |
| 2025Q4 | 9.26 | 100.14 | -0.9 | -1,452 | -1 | |
| 2025Q3 | 14.29 | 98.62 | -1.05 | -1,574 | -2 | |
| 2025Q2 | 13.05 | 99.67 | -1.95 | -2,689 | -3 | |
| 2025Q1 | 25.65 | 98.94 | -3.15 | -3,750 | -4 | |
| 2024Q4 | 31.5 | 101.25 | -2.4 | -2,751 | -3 | |
| 2024Q3 | 45.75 | 99.41 | -2.4 | -2,691 | -3 | |
| 2024Q2 | 41.7 | 100.73 | -2.25 | -2,203 | -2 | |
| 2024Q1 | 54.45 | 98.09 | -2.1 | -1,743 | -2 | |
| 2023Q4 | 18.75 | 101.21 | -0.75 | -668 | -1 | |
| 2023Q3 | 15 | 96.12 | -1.95 | -1,139 | -1 | |
| 2023Q2 | 10.95 | 89.19 | -1.8 | -1,114 | -1 | |
| 2023Q1 | 40.8 | -5.55 | -2,444 | -2 | ||
| 2022Q4 | 36.9 | 99.55 | -3.3 | -1,324 | -1 | |
| 2022Q3 | 36.75 | 95.82 | -4.5 | -1,695 | -2 | |
| 2022Q2 | 44.7 | 49.47 | -3.6 | -749 | -2 | |
| 2022Q1 | 49.5 | -6.15 | -2,418 | -2 | ||
| 2021Q4 | 60.45 | -3.6 | -1,449 | -1 | ||
| 2021Q3 | 93.9 | -5.25 | -2,003 | -2 | ||
| 2021Q2 | 105 | -3.6 | -1,303 | -1 |